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ABSTRACT 
 
Background 
 
The elderly are perceived as a high risk group for procedural sedation. Concerns may still exist 
regarding the safety of sedation of this patient group by emergency physicians, particularly when 
using propofol.  
 
Method 
 
We analysed prospectively collected data on patients aged 75 or over, undergoing sedation between 
October 2006 and March 2017. We used the World SIVA International Sedation Task Force adverse 
event tool, stratifying identified adverse events according to consensus agreement.  
 
Results 
 
Of 740 consecutive cases (median age 84 years) 571 patients received propofol, 142 morphine and 
midazolam and 27 other agents. We identified 19 sentinel events: 2 cases of hypoxia, 10 of apnoea 
(without hypoxia), 5 of hypotension and 2 of both hypoxia and hypotension. We also identified 30 
moderate, 41 minor and 7 minimal risk adverse events. There were no adverse outcomes.    
 
Conclusions 
 
We have demonstrated safe sedation practice in this high risk group of patients in this department. A 
sentinel adverse event rate of 2.6% including a hypoxia rate of 0.5%, with no adverse outcomes sets a 
benchmark for elderly sedation. We recommend quality pre-oxygenation, an initial propofol bolus of 
no more than 0.5mg/kg and a robust training and governance framework. 
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The safe provision of procedural sedation and analgesia is an essential skill required by emergency 
physicians
1
. Traditional use of benzodiazepine/ opioid combinations has been superseded by propofol 
in some Emergency Departments (EDs)
2
. Such practice is supported: Safe Sedation of Adults in the 
Emergency Department, a report and recommendations by the Royal College of Anaesthetists (RCoA) 
and the College of Emergency Medicine
3
. 
 
Elderly patients are more likely to be at risk from sedation given that many have co-morbidities, 
increased sensitivity to sedatives
4
 and limited physiological reserve. In a previous safety analysis of 
1008 adults sedated with propofol, we found that six of eleven cases with a sentinel adverse event 
were elderly
5
. In contrast, age was not a factor associated with complications in an analysis of 1402 
adult patients in a Scottish ED
6
. 
 
Since sedation is a common ED procedure, the UK population is ageing and the perceived sedative 
risk in this patient group, we explored the safety of our service for the elderly in greater detail, 
irrespective of sedative agent used.    
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METHODS 
 
We conducted an observational study using a prospectively collected database of patients undergoing 
sedation in our ED – one seeing 60 000 patients in 2007, rising to 90 000 in 2016. We used either 
propofol, morphine and midazolam or on occasions ketamine or 70% nitrous oxide, the latter alone or 
possibly in combination with other agents. Propofol was given according to our published guideline
7
. 
This has evolved and the current is illustrated in appx 1. Essentially patients received a 0.5 - 1 mg/kg 
bolus of propofol after 3 min of pre-oxygenation with a fraction of inspired oxygen (FiO2) as close to 
1 as possible. This was provided via a bag-valve-mask attached to high-flow oxygen and was 
continued until each patient was able to demonstrate adequate ventilatory effort. Smaller additional 
boluses were used for inadequate or prolonged sedation. Alternatively morphine and midazolam was 
used with discretion (for example, in the unwell, frail) or according to policy: senior physician 
unavailable. For all patients with fracture, dislocation or both, IV morphine given by paramedic crews 
was typically supplemented with further boluses according to pain score and response, before 
radiological investigation. 
 
We used the American Society of Anaesthesiologists’ (ASA) guideline on fasting requirements for 
elective surgery (adopted by the RCoA). On occasions, we allowed flexibility in clinically urgent 
cases (e.g. unstable patient requiring cardioversion, joint dislocation with neuropraxia) as previously 
discussed in a consensus-based clinical practice advisory
8. We routinely risk assessed each patient’s 
airway, using the respective ASA grading informally. We carefully considered the risk and benefit of 
procedural sedation, the target depth of sedation and selection of sedative agent(s) selection. Sedated 
patients were continuously monitored with pulse oximetry, respiratory rate (via transthoracic 
impedance trace), ECG and non-invasive blood pressure measured every five minutes. We introduced 
nasal capnography in late 2011. Each sedation episode was recorded on a dedicated electronic 
database, with emphasis on adverse events (problem, time, intervention, response and time to full 
recovery). 
 
We retrospectively applied the World SIVA International Sedation Task Force adverse event 
reporting tool
9  
(endorsed by the Royal College of Emergency Medicine) to the database from its 
inception in October 2006 to March 2017 (cf. our previous analysis
5 
: all adult cases from inception to 
2012). In addition, one of us cross-examined the original sedation chart for each patient in order to 
confirm events, detect those not recorded electronically and complete missing data. Three of us 
scrutinized cases in which an adverse event had been identified and stratified these according to 
consensus agreement.  
 
We confirm that our research and development directorate deemed that this study did not require 
patient consent or formal ethical review, as per the governance arrangements for Research and Ethics 
Committees in the UK. 
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RESULTS 
 
We identified and analysed 2931 patients. 740 of these were aged 75 years or older. Three were 
excluded since they had their sedation delivered by anaesthetists. Figure 1 illustrates the proportion of 
cases that were arbitrarily grouped: 75-79, 80-84 and 85+ years old. The ages ranged from 75 – 101 
years (median 84 years). 208 patients were male, 529 female. The clinical indication for sedation is 
demonstrated (Fig. 2). 571 patients received propofol, 142 morphine and midazolam and 27 other 
agents. We identified 97 adverse events and stratified in accordance with the SIVA tool 19 of these as 
sentinel, 30 as moderate, 41 as minor and seven as a minimal risk adverse event. Of the sentinel cases, 
two related to hypoxia, ten to apnoea (without hypoxia), five to hypotension requiring the need for 
pressor treatment and two cases related to both hypoxia and hypotension. Five of the 19 cases 
involved midazolam, 14 propofol. We describe each sentinel case in table 1.The number of sentinel 
events each year are depicted in Fig 3. The sentinel event rate in each age group is demonstrated in 
Fig 4. The overall sentinel adverse event rate was 2.6%. 
 
We failed to retrieve the original sedation chart in 70 cases, either because the chart had not been 
scanned (20), or the incorrect hospital number had been recorded on the database(27) or not recorded 
at all (23). We included all 70 patients within the analysis, using the evidence recorded within the 
database and where possible accessing the patients’ hospital records. None of these had a sentinel 
adverse event; four had moderate. The remainder had either lesser or no adverse events.  
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DISCUSSION  
This study suggests that sedation practice for elderly patients in this department is safe. Whilst we 
recognise that the overall adverse event rate is more than twice that of our previous analysis of 
sedated adults (2.6 vs 1.1%), the incidence of hypoxia was 0.5% in both studies. This compares 
favourably with hypoxia rates identified with electronically recorded pulse oximetry during non-
cardiac adult anaesthesia of 10.3%
9
. Ten of the 19 sentinel cases in our series had neither hypoxia nor 
hypotension. There were no adverse outcomes. 
On analysis, two particular points are noteworthy: 
• As per our previous recommendation5 a smaller propofol bolus (0.5mg/kg) and smaller 
subsequent boluses (0.25mg/kg) may have limited or prevented both respiratory and cardiovascular 
complications. Only three (cases12, 13 and 18) of the 14 sentinel cases given propofol had the doses 
in line with this recommendation. This likely represents a responsive change in practice from 2013. 
• The merit of quality pre-oxygenation (as per propofol protocol) protected the majority of 
apnoeic patients from hypoxia: nine of the 12 patients meeting the World SIVA definition of apnoea 
did not become hypoxic. 
The number of adverse events per year (Fig 4) appears patternless. Neither is it possible to draw any 
meaningful conclusions when comparing event rates between propofol and morphine and midazolam. 
The latter combination may have deliberately been selected for the frail elderly; on deeper analysis all 
five sentinel events were supervised by a consultant, confounding the notion that these would be more 
likely with a lone middle grade, a risk factor previously identified by Scottish colleagues
6
. 
The sentinel event rate in the three age groups (Fig 3) fails to demonstrate a trend; the increased rate 
in the most elderly group is not statistically significant. The adverse event rate of 2.6% nevertheless 
endorses caution: robust training and governance is required to support their sedation.   
We recognize limitations to our study: 
  (likely) poor recording of prolonged apnoea in the database and sedation charts. Propofol 
typically causes brief apnoea or change in respiratory pattern at onset, and the duration of this 
may not be accurately timed, especially when expected and not associated with hypoxia due 
to appropriate use of pre-oxygenation 
 intermittent saturation recording could potentially miss significant desaturation. Future study 
might therefore incorporate continuous electronic saturation data capture 
 the possibility of variable reporting of events by staff. However, real time recording of data 
onto the e-database is mandated in the department and reinforced on annual, open audit as 
part of the governance framework 
 the failure to find and cross-examine the original sedation chart of 73 patients  
In conclusion, we have demonstrated safe sedation practice in this high risk group of patients in this 
emergency department. A sentinel adverse event rate of 2.6% including a hypoxia rate of 0.5%, with 
no adverse outcomes sets a benchmark for elderly sedation. We recommend quality pre-oxygenation, 
an initial propofol bolus of no more than 0.5mg/kg (and subsequent doses of 0.25mg/kg) and a robust 
training and governance framework.  
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Figure 4: Sentinal events by age group   
Total number of patients Without sentinal events With sentinal events
13 
 
 
 
14 
 
Sentinel 
Event  
Age Sex Diagnosis Co-morbidities /relevant drugs Pre-hospital analgesia  Pre-procedural 
crystalloid 
Doses of IV sedative 
agent 
Adverse Event Management 
          ED analgesia         
1 84 M Dislocation of prosthetic 
hip 
Vascular dementia, hypertension 
(atenolol and frusemide) 
  1000ml Propofol 1mg/kg  Hypotension 73/58 
(baseline 130/70); 'well 
perfused' recorded  
Metaraminol 1mg 
          Morphine 10mg IV         
2 78 F Fractured tibia and fibula Multiple sclerosis, ischaemic heart 
disease 
Oral morphine 10mg 1000ml Propofol 1mg/kg  Hypotension 78/30 
(baseline 125 systolic)  
Metaraminol 0.5mg 
          Morphine 5mg  oral, 
Morphine 15mg IV 
        
3 85 F Fracture dislocation 
shoulder 
Fluid retention (frusemide) Nitrous oxide, 
Morphine 10mg IV  
Not documented Propofol 1mg/kg  Hypoxia (Sats 70%) BVM ventilation < 60s 
                    
4 75 M Fractured elbow Polymyalgia rheumatica, hypertension 
(candesartan) 
Morphine 10mg oral Not documented Propofol 1mg/kg  Apnoea >60s Resolved without need 
for BVM (no drop in O2 
saturation) 
          IV morphine 7.5mg         
5 88 F Fast atrial fibrillation 
(120-170bpm) with  
chest pain 
Type 2 diabetes mellitus, hypertension 
(lisinopril) 
  250ml Propofol 1mg/kg 
initially, then 
0.5mg/kg  
Hypotension 75 systolic 
(baseline 170/65) 
Metaraminol 0.25mg 
with prompt response 
                    
6 87 F Dislocation of prosthetic 
hip 
Fluid retention (bendroflumethiazide) Morphine 5mg IV, 
nitrous oxide 
500ml  Propofol 1mg/kg  Apnoea >60s BVM ventilation, no drop 
in O2 saturation 
                    
7 77 F Fractured tibia and fibula None relevant IV morphine 20mg Not documented Propofol 1mg/kg  Apnoea >60s BVM ventilation, no drop 
in O2 saturation 
                    
8 76 M Dislocation of prosthetic 
hip 
None relevant None Not documented Midazolam 5mg 
bolus 
Apnoea >60s  Flumazenil. No recorded 
drop in O2 saturation 
15 
 
              Fentanyl 50mcg     
9 77 M Dislocation of prosthetic 
hip 
Hypertension (captopril, amlodipine, 
atenolol) 
Entonox 1000ml Propofol 1mg/kg  Apnoea 3 minutes Resolved without need 
for BVM (no drop in O2 
saturation) 
          Morphine 10mg          
10 78 F Dislocation of prosthetic 
hip 
Permenant pacemaker (spironolactone, 
frusemide) 
  1000ml Propofol 1mg/kg  Hypotension 85 systolic 
(baseline 120/50) 
Metaraminol 0.25mg 
          IV morphine 10mg         
11 79 M Dislocation of prosthetic 
hip 
Ischaemic heart disease (metoprolol) Not documented 1000ml Midazolam 14mg 
titrated 
Apnoea >60s BVM assisted ventilation. 
No drop in O2 saturation. 
          Morphine 1-10mg IV 
(exact dose not 
recorded) 
  Fentanyl 100mcg   Naloxone and flumazenil 
500mcg 
12 89 F Dislocation of prosthetic 
hip and stroke 
Diabetes mellitus, hypertension, 
cerebrovascular event (frusemide, 
lercanidipine, ramipril) 
  500ml  Propofol 0.5mg/kg 
initially, then 0.5 
mg/kg 
Hypotension 65 systolic 
(baseline 100/30) 
Metaraminol 2mg 
          IV morphine 7mg          
13 93 F Dislocation of prosthetic 
hip 
Atrial fibrillation (digoxin) Morphine 20mg IV 
titrated 
1000ml Propofol 0.5mg/kg 
initially, then 0.5 
mg/kg, then 
0.5mg/kg 
Apnoea >60s with 
hypoxia (sats 85%) 
Airway manouevres and 
BVM assisted ventilation 
                    
14 82 F Colles fracture and 
allergy to local 
anaesthetic 
None relevant None 500ml Midazolam 2mg  Hypotension 76/55 
(baseline 118/65) 
Metaraminol 0.25mg and 
crystalloid challenge 
                    
15 88 F Fractured tibia and fibula None relevant IV morphine 15mg, 
entonox 
Not documented Propofol 1mg/kg  
initially then 
0.5mg/kg 
Apnoea 2-3 minutes Resolved without need 
for BVM (no drop in O2 
saturation) 
                    
16 
 
16 80 F Shoulder dislocation None relevant Morphine 15mg IV 500ml  Propofol 0.5mg/kg  
initially then 
0.5mg/kg 
Apnoea 2 minutes Resolved without need 
for BVM (no drop in O2 
saturation) 
                    
17 95 F Shoulder dislocation Atrial fibrillation, hypertension, heart 
failure (atenolol, doxazocin) 
None Not documented Midazolam 2mg IV Apnoea >60s BVM assisted ventilation 
(no drop in O2 
saturation) 
                  Flumazenil 150mcg 
18 92 M Ventricular Tachycardia 
with intermittent chest 
pain and hypotension 
85/61 
Coronary artery bypass graft (ramipril, 
frusemide) 
None 500ml  Midazolam 2mg IV Hypoxia (Sats 82% for 
>60s), hypotension 
73/51 
Not noted 
                    
19 90 F Dislocation of prosthetic 
hip 
Permenant pacemaker, hypertension, 
atrial fibrillation (metoprolol, frusemide) 
None 500ml  Propofol 0.5mg/kg, 
followed by fentanyl 
100mcg  
Hypoxia (Sats 86%), 
hypotension 54/40 
Airway manouevres,  
Metaraminol 1mg,  
Naloxone 400mcg 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
